CCTST hosts virtual meeting on aging January 17
All welcome to attend
The Center for Clinical and Translational Science and Training (CCTST) Collaboration Network is hosting a virtual meeting on aging for educators, researchers and healthcare providers across UC, Children’s Hospital, UC Health, the Cincinnati VA, and the Greater Cincinnati community who are interested in the field of aging. The meeting will be held Thursday, January 17 from 9-11 a.m., and will be moderated by Jack Kues, PhD, director of the CCTST Center for Improvement Science.
All are invited to visit one of several convenient locations around the UC campus and other partner institutions where people can meet and participate remotely via WebEx to explore the CCTST’s institutional and community-wide expertise and capacity for research, education and community programs on aging.
To join one of the WebEx-enabled meeting locations, or to join us from your home or office, please visit our event website at: https://cctst.uc.edu/programs/cis/collaboration
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.